Transhumanism

$100M XPRIZE for Carbon Removal Funded by Elon Musk to Fight Climate Change

Retrieved on: 
Monday, February 8, 2021
Technology, Manufacturing, Philanthropy, Other Natural Resources, Other Science, Other Technology, Natural Resources, Foundation, Environment, Engineering, Science, Businesspeople, Non-profit organizations based in California, Transhumanism, X Prize Foundation, Elon Musk, XPRIZE, The Musk Foundation

XPRIZE , the worlds leader in designing and launching incentive competitions to solve humanitys grand challenges, today announced the $100M XPRIZE Carbon Removal sponsored by Elon Musk and the Musk Foundation.

Key Points: 
  • XPRIZE , the worlds leader in designing and launching incentive competitions to solve humanitys grand challenges, today announced the $100M XPRIZE Carbon Removal sponsored by Elon Musk and the Musk Foundation.
  • The objective of this XPRIZE is to inspire and help scale efficient solutions to collectively achieve the 10 gigaton per year carbon removal target by 2050, to help fight climate change and restore the Earths carbon balance.
  • Through XPRIZE Carbon Removal competition, the teams are invited to make history and become our climate heroes by reshaping our future.
  • Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, $10 Million XPRIZE Rainforest, $10 Million ANA Avatar XPRIZE, $6 Million XPRIZE Rapid COVID Testing, the $5 Million IBM Watson AI XPRIZE, $5 Million XPRIZE Rapid Reskilling, and $500K Pandemic Response Challenge.

Life Extension's clinically-studied nutritional supplement supports healthy urinary function

Retrieved on: 
Tuesday, February 2, 2021
Demography, Articles, Ageing, Life extension, Population, Transhumanism, Urinary incontinence, Time

Late-night trips to the bathroom might seem like a rite of passage to some men, explained Dr. Swick, Chief Science Officer for Life Extension .

Key Points: 
  • Late-night trips to the bathroom might seem like a rite of passage to some men, explained Dr. Swick, Chief Science Officer for Life Extension .
  • But getting a good nights sleep is important: it can lead to a better quality of life, improve physical and mental health.
  • The results are very encouraging, said Dr. Marianne Pons, a Senior Scientist at Life Extension and co-author of the published article.
  • A leader in science-based nutritional supplements for over 40 years, Life Extension will continue to contribute innovations like Mens Bladder Control in the future, Dr. Swick added.

Foresight Research: In the Middle of the Pandemic the Central Florida Auto Show was Conducted. How Did It Go?

Retrieved on: 
Tuesday, January 26, 2021
States of the United States, United States, Country subdivisions, Foresight, Transhumanism, Orlando, Florida, Auto show, Florida, Coronavirus disease

The Central Florida auto show was held in Orlando from December 18 to December 20 after postponing the dates originally planned.

Key Points: 
  • The Central Florida auto show was held in Orlando from December 18 to December 20 after postponing the dates originally planned.
  • Foresight Research immediately following the show interviewed 645 Orland residents some who attended the auto show and some that did not attend the auto show.
  • The 2020 Central Florida International Auto Show Focus Report details the impact that the COVID-19 virus has on auto shows.
  • Foresight Research covers a wide range of subjects with emphasis on auto shows, motorsports, experiential events, and vehicle accessories.

Foresight Research: Public Relations is almost tied with TV when it comes to influencing automotive purchasers

Retrieved on: 
Tuesday, January 26, 2021
Futures studies, Foresight, Transhumanism, Advertising, Articles, Academic disciplines

Respondents are asked a lot of questions, but one is what marketing communications channel influenced them to buy their vehicle.

Key Points: 
  • Respondents are asked a lot of questions, but one is what marketing communications channel influenced them to buy their vehicle.
  • For 2020, a new report is now available from Foresight Research that does a deep dive into the power of automotive public relations.
  • Since 1998, Foresight Research has been providing consumer insights and data to support strategies and best practices for the automotive industry.
  • Foresight Research is a recognized leader in measuring auto shows, experiential marketing/sponsored events, as well as automotive public relations, vehicle accessories and motorsports.

‘The New Eugenics’ examines the implications of various biotechnologies for humankind

Retrieved on: 
Tuesday, January 12, 2021
Branches of biology, Medicine, Genetics, Bioethics, Applied genetics, Medical genetics, Transhumanism, Medical ethics, Eugenics, Preimplantation genetic diagnosis, New eugenics, Genetic testing

The author argues that increasingly, scientists believe that improving the health, environment, and safety of humankind justifies the risks.

Key Points: 
  • The author argues that increasingly, scientists believe that improving the health, environment, and safety of humankind justifies the risks.
  • The book encompasses many biotechnologies within the definition of the new eugenics because these technologies are used to improve the stock, when the stock in this case are all humans.
  • In addition to discussing the new genetics in terms of in vitro fertilization and PGD (preimplantation genetic diagnosis) like other researchers, Quintyn talks about other biotechnologies as well.
  • The New Eugenics is available for purchase online at the Archway link above, Barnes & Noble and Amazon at: https://www.amazon.com/New-Eugenics-Modifying-Biological-Twenty-first/dp... .

Nanomix Selected as Finalist in XPRIZE Rapid COVID Testing Competition

Retrieved on: 
Tuesday, January 5, 2021
Research, Pharmaceutical, Technology, Medical devices, Infectious diseases, Hospitals, Genetics, Clinical trials, Science, Nanotechnology, Biotechnology, FDA, Health, Medicine, Clinical medicine, Non-profit organizations based in California, Transhumanism, X Prize Foundation, Medical specialties, Immunologic tests, COVID-19 testing, Coronavirus disease, ELISA, Nanomix, XPRIZE Rapid COVID Testing

Nanomix, a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that XPRIZE has selected the companys eLab COVID-19 assay as a finalist in the XPRIZE Rapid COVID Testing competition.

Key Points: 
  • Nanomix, a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that XPRIZE has selected the companys eLab COVID-19 assay as a finalist in the XPRIZE Rapid COVID Testing competition.
  • XPRIZE Rapid COVID Testing competition is inspiring the best entrepreneurs and scientists to form teams and come together to work towards rapid, affordable COVID-19 testing at scale, and ultimately, getting the world up and running again.
  • We are excited to be selected as a finalist in the XPRIZE Rapid COVID Testing, said David Ludvigson, CEO of Nanomix.
  • The eLab Rapid COVID Antigen test, together with our eLab Rapid COVID Antibody test, form a complete offering for COVID-19 testing.

XPRIZE Announces Winners of Million Dollar Next-Gen Mask Challenge to Reveal the Next Generation of Face Masks Following a Virtual Pitch Slam

Retrieved on: 
Tuesday, December 22, 2020
Research, Philanthropy, Family, Consumer, Infectious diseases, Other Manufacturing, Fashion, Foundation, Retail, Science, Medical Supplies, Health, Manufacturing, Non-profit organizations based in California, Transhumanism, X Prize Foundation

The team of five felt compelled to spring into action after witnessing the devastating impact the COVID-19 pandemic had on their Arizona community.

Key Points: 
  • The team of five felt compelled to spring into action after witnessing the devastating impact the COVID-19 pandemic had on their Arizona community.
  • Their participation in the XPRIZE Next-Gen Mask Challenge was driven by their desire to design a better way to protect those that choose to wear a mask and help communities around the world.
  • When we started this journey, we wanted to create awareness among young people for the need to wear masks.
  • Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, the $10 Million Rainforest XPRIZE, the $10 Million ANA Avatar XPRIZE, the $5 Million IBM Watson AI XPRIZE and the $5 Million XPRIZE Rapid Reskilling.

Menon Advances as Finalist in $6 Million XPRIZE Rapid COVID Testing Competition with Molecular Mirror™ Platform Technology

Retrieved on: 
Tuesday, December 22, 2020
Non-profit organizations based in California, Transhumanism, X Prize Foundation, COVID-19 testing, Coronavirus disease, Articles, Medicine, Infectious diseases

XPRIZE Rapid COVID Testing is a six-month competition to develop faster, cheaper and easier-to-use COVID-19 testing methods at scale.

Key Points: 
  • XPRIZE Rapid COVID Testing is a six-month competition to develop faster, cheaper and easier-to-use COVID-19 testing methods at scale.
  • Finalist teams will have two weeks to send their testing kits and protocols to two separate laboratories for clinical validation.
  • "The Molecular Mirror, is a novel, minimal-cost detection platform that enables rapid visualization of an invisible enemy: the SARS-CoV-2 virus.
  • Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, $10 Million XPRIZE Rainforest, $15 Million XPRIZE Feed the Next Billion, $10 Million ANA Avatar XPRIZE, $6 Million XPRIZE Rapid COVID Testing, $5 Million IBM Watson AI XPRIZE, $5 Million XPRIZE Rapid Reskilling, $1 Million XPRIZE Next-Gen Mask Challenge and $500,000 Pandemic Response Challenge.

ChromaCode Named Finalist in XPRIZE Rapid Covid Testing Competition

Retrieved on: 
Tuesday, December 22, 2020
Non-profit organizations based in California, Transhumanism, X Prize Foundation, Articles, Science and technology, Branches of biology, COVID-19 testing, Anousheh, Polymerase chain reaction

CARLSBAD, Calif., Dec. 22, 2020 /PRNewswire/ -- ChromaCode, Inc. today announced that the company has been named a finalist in the $6 million XPRIZE Rapid Covid Testing competition, a six-month competition to develop faster, cheaper and easier-to-use COVID-19 testing methods at scale.

Key Points: 
  • CARLSBAD, Calif., Dec. 22, 2020 /PRNewswire/ -- ChromaCode, Inc. today announced that the company has been named a finalist in the $6 million XPRIZE Rapid Covid Testing competition, a six-month competition to develop faster, cheaper and easier-to-use COVID-19 testing methods at scale.
  • "Fast, affordable and accessible testing is crucial to containing the COVID-19 pandemic and safely reopening schools, businesses and other vital institutions around the world," said Anousheh Ansari, CEO of XPRIZE.
  • "We're honored and excited to be selected as an XPRIZE finalist and look forward to working on our shared objectives."
  • "ChromaCode's HDPCR leverages the sensitivity and specificity of real-time PCR the gold standard for molecular testing," said Chris MacDonald, Vice President of Operations & Data Science at ChromaCode.

Finalists Selected in $6 Million XPRIZE Rapid Covid Testing Competition to Help Restart Global Economy

Retrieved on: 
Tuesday, December 22, 2020
Other Health, Research, General Health, Philanthropy, Infectious diseases, Foundation, Science, Biotechnology, Medical Supplies, Other Philanthropy, Other Science, Health, Transhumanism, Non-profit organizations based in California, X Prize Foundation

XPRIZE is a global future-positive movement of over 1M people and rising, delivering truly radical breakthroughs for the benefit of humanity.

Key Points: 
  • XPRIZE is a global future-positive movement of over 1M people and rising, delivering truly radical breakthroughs for the benefit of humanity.
  • Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, $10 Million XPRIZE Rainforest, $15 Million XPRIZE Feed the Next Billion, $10 Million ANA Avatar XPRIZE, $6 Million XPRIZE Rapid Covid Testing, $5 Million IBM Watson AI XPRIZE, $5 Million XPRIZE Rapid Reskilling, $1 Million Next-Gen Mask Challenge and $500,000 Pandemic Response Challenge.
  • Through its affiliated companies, Anthem serves more than 107 million people, including more than 43 million within its family of health plans.
  • All of these firms will contribute to evaluating and scaling up technologies that Covid Apollo will accelerate.